Come up with a name for your new list and we'll add to it:
Cyteir Therapeutics raised a round of funding on June 29, 2016. Investors include
National Cancer Institute.
Cyteir Therapeutics is involved in the discovery and development of novel therapeutics based on the biology of DNA repair and synthetic lethality for the treatment of cancer and autoimmune diseases. T…